Expeditors International of Washington (NASDAQ:EXPD): Hedge Funds and Insiders Are Bearish, What Should You Do?

Expeditors International of Washington (NASDAQ:EXPD) shareholders have witnessed a decrease in hedge fund interest in recent months.

To most stock holders, hedge funds are viewed as underperforming, outdated financial vehicles of the past. While there are greater than 8000 funds trading at the moment, we look at the aristocrats of this club, close to 450 funds. It is widely believed that this group has its hands on the majority of the smart money’s total capital, and by keeping an eye on their highest performing picks, we have spotted a number of investment strategies that have historically outperformed the market. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outclassed the S&P 500 index by 25 percentage points in 6.5 month (see the details here).

Equally as important, positive insider trading activity is a second way to parse down the investments you’re interested in. There are a number of incentives for an executive to drop shares of his or her company, but only one, very clear reason why they would initiate a purchase. Many empirical studies have demonstrated the valuable potential of this strategy if “monkeys” understand what to do (learn more here).

Now, let’s take a glance at the key action surrounding Expeditors International of Washington (NASDAQ:EXPD).

Hedge fund activity in Expeditors International of Washington (NASDAQ:EXPD)

Heading into 2013, a total of 24 of the hedge funds we track were bullish in this stock, a change of -4% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were upping their stakes considerably.

Of the funds we track, Merchants’ Gate Capital, managed by Jason Capello, holds the largest position in Expeditors International of Washington (NASDAQ:EXPD). Merchants’ Gate Capital has a $235 million position in the stock, comprising 10.5% of its 13F portfolio. The second largest stake is held by Charles de Vaulx of International Value Advisers, with a $193 million position; 0.2% of its 13F portfolio is allocated to the company. Other hedgies with similar optimism include Ken Griffin’s Citadel Investment Group, Chuck Royce’s Royce & Associates and Steven Cohen’s SAC Capital Advisors.

Because Expeditors International of Washington (NASDAQ:EXPD) has faced bearish sentiment from the smart money, we can see that there is a sect of hedgies that elected to cut their positions entirely at the end of the year. Intriguingly, Michael Larson’s Bill & Melinda Gates Foundation Trust said goodbye to the biggest stake of the “upper crust” of funds we monitor, valued at an estimated $67 million in stock., and Israel Englander of Millennium Management was right behind this move, as the fund cut about $4 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest was cut by 1 funds at the end of the year.

How are insiders trading Expeditors International of Washington (NASDAQ:EXPD)?

Insider trading activity, especially when it’s bullish, is at its handiest when the primary stock in question has seen transactions within the past half-year. Over the latest 180-day time period, Expeditors International of Washington (NASDAQ:EXPD) has seen zero unique insiders buying, and 8 insider sales (see the details of insider trades here).

With the returns shown by our tactics, retail investors must always monitor hedge fund and insider trading sentiment, and Expeditors International of Washington (NASDAQ:EXPD) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!